Insider Purchases: Inside the Buy
Tag: #FUNanc1al
🏛️ S&P Global (SPGI): The Toll Booth of Capitalism Gets a “Sale” Sign
S&P Global isn’t just a company—it’s the infrastructure of modern finance. With valuation down ~30% and insiders buying, is this a rare opportunity to own a wide-moat compounder at a discount?
🩺 GE HealthCare (GEHC): Insider Buying, AI Growth & a $21B Backlog Opportunity
GE HealthCare (GEHC) is quietly shaping up as a high-visibility MedTech play, combining insider buying, a $21.8B backlog, and AI-driven diagnostics. With valuation still reasonable and institutional ownership near record levels, this could be a compelling long-term compounder—if you’re patient on entry.
📡 Charter Communications (CHTR): 4x P/E, 23% Short Interest — Value Play or Squeeze Setup?
Charter Communications (CHTR) is down ~79% from its highs but trades at just 4x earnings. With insider buying, heavy short interest, and massive buybacks, is this a deep value play—or a cable trap?
🍫 Simply Good Foods (SMPL): Low Carb, Low Price, or Just Low Expectations?
Simply Good Foods (SMPL) is down sharply, trading at bargain-style valuation levels while insiders keep buying. Is this protein-packed stock a turnaround snack—or a melting low-carb ice cube?
🏦 Home BancShares (HOMB): The Banker Who Puts His Money Where His Vault Is
Home BancShares may not be flashy, but the CEO’s $2.7 million stock purchase, cheap valuation, and steady banking fundamentals make HOMB a compelling slow-and-solid compounder to watch in 2026.
Badger Meter (BMI) Stock Analysis 2026: Insider Buys After 24% Crash 💧📉
Badger Meter just took a 24% hit—but the CEO is buying the dip. With strong long-term water infrastructure trends and improved valuation, is BMI a hidden opportunity or just treading water?
🛡️ Okta (OKTA): The AI Identity Moat Is Getting Cheaper
Okta is no longer just a high-growth story—it’s becoming a profitable identity powerhouse in the age of AI. With improving margins, strong institutional backing, and a new insider buy, the question is simple: is this a turnaround… or just the beginning?
Conagra (CAG): 9% Yield Bargain or Value Trap? 🥫📉
Conagra (CAG) is down big, insiders are buying, and the dividend is near 9%. Is this a deep-value opportunity—or a trap in disguise? 🥫
$500K Insider Bet at 52-Week Lows: Is Shoe Carnival (SCVL) a Hidden Gem? 👟
Shoe Carnival (SCVL) is trading near lows with a $500K insider buy, high short interest, and ultra-cheap valuation. Is this a hidden value play—or a classic trap? 👟
📈 Top 10 Insider Buys April 2026: CEOs Buying OSCR, NKE, LW & More
CEOs, directors, and 10% owners are writing real checks again. From Oscar Health’s massive $11.9M buy to Nike’s continued dip-buying, here are the most interesting insider moves of April 2026.